Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,111 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Significance of monitoring trough plasma concentration levels for invasive fungal infection prophylaxis with itraconazole oral solution in patients with hematological malignancies: a prospective study].
Kawano I, Matsumoto K, Jiromaru T, Jinnochi F, Semba Y, Sugio T, Sakamoto K, Saito N, Yoshida S, Henzan H, Takase K, Morita K, Eto T. Kawano I, et al. Among authors: takase k. Rinsho Ketsueki. 2016;57(12):2475-2480. doi: 10.11406/rinketsu.57.2475. Rinsho Ketsueki. 2016. PMID: 28090013 Japanese.
Reconstitution of HLA-A*2402-restricted cytomegalovirus-specific T-cells following stem cell transplantation.
Gondo H, Himeji D, Kamezaki K, Numata A, Tanimoto T, Takase K, Aoki K, Henzan H, Nagafuji K, Miyamoto T, Ishikawa F, Shimoda K, Inaba S, Tsukamoto H, Horiuchi T, Nakashima H, Otsuka T, Kato K, Kuroiwa M, Higuchi M, Shibuya T, Kamimura T, Kuzushima K, Tsurumi T, Kanda Y, Harada M. Gondo H, et al. Among authors: takase k. Int J Hematol. 2004 Dec;80(5):441-8. doi: 10.1532/ijh97.04109. Int J Hematol. 2004. PMID: 15646657
Oral valganciclovir as preemptive therapy is effective for cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients.
Takenaka K, Eto T, Nagafuji K, Kamezaki K, Matsuo Y, Yoshimoto G, Harada N, Yoshida M, Henzan H, Takase K, Miyamoto T, Akashi K, Harada M, Teshima T; for Fukuoka Blood and Marrow Transplant Group (FBMTG). Takenaka K, et al. Among authors: takase k. Int J Hematol. 2009 Mar;89(2):231-237. doi: 10.1007/s12185-008-0249-2. Epub 2009 Jan 17. Int J Hematol. 2009. PMID: 19148587 Clinical Trial.
Long-term outcomes of autologous PBSCT for peripheral T-cell lymphoma: retrospective analysis of the experience of the Fukuoka BMT group.
Numata A, Miyamoto T, Ohno Y, Kamimura T, Kamezaki K, Tanimoto T, Takase K, Henzan H, Kato K, Takenaka K, Fukuda T, Harada N, Nagafuji K, Teshima T, Akashi K, Harada M, Eto T; Fukuoka Blood and Marrow Transplantation Group. Numata A, et al. Among authors: takase k. Bone Marrow Transplant. 2010 Feb;45(2):311-6. doi: 10.1038/bmt.2009.165. Epub 2009 Jul 13. Bone Marrow Transplant. 2010. PMID: 19597416
Role of autotransplantation in the treatment of acute promyelocytic leukemia patients in remission: Fukuoka BMT Group observations and a literature review.
Kamimura T, Miyamoto T, Nagafuji K, Numata A, Henzan H, Takase K, Ito Y, Ohno Y, Fujisaki T, Eto T, Takamatsu Y, Teshima T, Gondo H, Akashi K, Taniguchi S, Harada M. Kamimura T, et al. Among authors: takase k. Bone Marrow Transplant. 2011 Jun;46(6):820-6. doi: 10.1038/bmt.2010.207. Epub 2010 Sep 6. Bone Marrow Transplant. 2011. PMID: 20818443
Initial low-dose valganciclovir as a preemptive therapy is effective for cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients.
Takenaka K, Nagafuji K, Takase K, Kamimura T, Mori Y, Ito Y, Nishi Y, Henzan H, Kato K, Harada N, Eto T, Miyamoto T, Teshima T, Akashi K. Takenaka K, et al. Among authors: takase k. Int J Hematol. 2012 Jul;96(1):94-100. doi: 10.1007/s12185-012-1087-9. Epub 2012 May 1. Int J Hematol. 2012. PMID: 22547196 Clinical Trial.
1,111 results